Fast Five Quiz: Type 2 Diabetes and Dyslipidemia

Anne L. Peters, MD

Disclosures

May 16, 2022

Statins are the drug of choice for lowering LDL cholesterol levels and for primary and secondary prevention of ASCVD in all patients with and without CVD. According to the American Diabetes Association, in addition to lifestyle and glycemic therapy, it is recommended that all patients with type 2 diabetes without CVD between the ages 40 and 75 years use a moderate-intensity statin therapy. High-intensity statins are recommended in patients with risk factors for or established CVD. Moderate-intensity and high-intensity statin therapies have been shown to reduce LDL cholesterol by 30%-49% and ≥ 50%, respectively.

Learn more about type 2 diabetes.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....